Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis.
about
Biomaterial delivery of morphogens to mimic the natural healing cascade in boneVascular endothelial growth factors enhance the permeability of the mouse blood-brain barrierSequential release of nanoparticle payloads from ultrasonically burstable capsules.Targets and delivery methods for therapeutic angiogenesis in peripheral artery diseasePerspectives and opportunities for nanomedicine in the management of atherosclerosis.Evaluation of inflammatory response to acute ischemia using near-infrared fluorescent reactive oxygen sensorsNanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia.Concise review: injectable biomaterials for the treatment of myocardial infarction and peripheral artery disease: translational challenges and progress.Positron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with 64Cu-labeled TRC105125I-labeled gold nanorods for targeted imaging of inflammation.Nanomedical Theranostics in Cardiovascular Disease.Micro- and Nanoparticles for Treating Cardiovascular Disease.Green Synthetic Approach for Synthesis of Fluorescent Carbon Dots for Lisinopril Drug Delivery System and their Confirmations in the Cells.VEGF-loaded graphene oxide as theranostics for multi-modality imaging-monitored targeting therapeutic angiogenesis of ischemic muscle.Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease.Nonporous Silica Nanoparticles for Nanomedicine Application.Photoluminescent carbon nanotags from harmful cyanobacteria for drug delivery and imaging in cancer cells.From nano- to macro-scale: nanotechnology approaches for spatially controlled delivery of bioactive factors for bone and cartilage engineering.Emerging advances in nanomedicine with engineered gold nanostructures.Nanotechnology for protein delivery: Overview and perspectives.Delivering therapeutics in peripheral artery disease: challenges and future perspectives.Re-assessing the enhanced permeability and retention effect in peripheral arterial disease using radiolabeled long circulating nanoparticles.Copper Prussian blue analogue: investigation into multifunctional activities for biomedical applications.Bioconjugated gold nanoparticles accelerate the growth of new blood vessels through redox signaling.Angiopep-conjugated electro-responsive hydrogel nanoparticles: therapeutic potential for epilepsy.Attenuation of endothelial-dependent vasodilator responses, induced by dye-encapsulated silica nanoparticles, in aortic vessels.Polymeric nanomaterials for islet targeting and immunotherapeutic delivery.Enzyme-Responsive Nanoparticles for Targeted Accumulation and Prolonged Retention in Heart Tissue after Myocardial InfarctionSwitchable Release of Entrapped Nanoparticles from Alginate Hydrogels.Nanoflowers: a future therapy for cardiac and ischemic disease?Coxsackievirus B3 used as a gene therapy vector to express functional FGF2.Enzyme-Targeted Nanoparticles for Delivery to Ischemic Skeletal Muscle.Cell-Based Drug Delivery and Use of Nano-and Microcarriers for Cell Functionalization.Biocompatibility of amorphous silica nanoparticles: Size and charge effect on vascular function, in vitro.Design and characterization of hydrogel nanoparticles with tunable network characteristics for sustained release of a VEGF-mimetic peptide.Timed Delivery of Therapy Enhances Functional Muscle Regeneration.Precise diagnosis in different scenarios using photoacoustic and fluorescence imaging with dual-modality nanoparticles.In Vivo Ischemia Detection by Luminescent Nanothermometers.The influence of silica nanoparticles on small mesenteric arterial function.In vivo monitoring of angiogenesis in a mouse hindlimb ischemia model using fluorescent peptide-based probes.
P2860
Q26996479-E5FF2231-DF71-43B9-B0A3-50C9418BA05FQ28539799-BF556571-034B-48DC-867C-14243A6347E6Q30366620-60DD0714-5863-49A7-A765-5AA5924467D9Q30449821-7DF63371-D323-4BC5-AB97-960CC40EDD5EQ30455490-401E9DCD-B96E-4493-A100-A1CBDD2FACDCQ30573161-FDA9E5AA-70E3-4596-8CEB-A2F030CBAF6EQ33864915-8C89568D-A80C-41A7-A3F5-045C645A4444Q34109419-C9FF6256-4CD2-4683-A910-512251E97DF8Q34759659-3F711C51-7DAD-438B-8369-167B21C71B1FQ35569270-285EC361-A273-4959-9786-8349B1E22117Q35681183-ADCF92B1-F2B9-46B4-ADE6-370E850E2BD6Q35801354-69C03624-597A-473F-A08B-F440E5827277Q36146654-6B5927A2-4559-42F6-9B34-35298F8BBC40Q36165427-040DA5B5-437D-48D4-B4DC-A5FA14C9341FQ37123107-113ED477-E992-4482-AE02-BCE5D6B999F2Q37131939-BACB6A6E-0E7F-45D4-886F-48196B2DC20AQ37697822-3A296BC0-EBB5-466A-9066-EFFAC65BFC7EQ38030641-CAD8B4BF-33A1-4275-A5DF-51FD36567A3AQ38180306-FE6DC9E9-3E50-4213-96D8-2BA6D4DAF404Q38605185-07BA7E99-554C-4A58-ABE0-37217E7FD446Q38842808-6BA5AF8D-7B1F-4EC9-8A06-EC142F1820D1Q38859160-6F7810E7-3778-45EE-A6BA-913B7ABF91E2Q38893500-98F7038F-5410-4166-BBCB-A7295F0C2867Q38949558-517043BC-110F-484C-8C0A-08ECD4DFC1C2Q38973444-5D596043-6424-4E70-A536-73D2EE5C8CD8Q39463167-61F8372C-B058-4CE8-832B-16068685EACFQ41142767-58188317-5E7D-443B-9C56-993FA14F42CDQ41295473-3D4E2C02-01CB-4E7D-81B8-391DF13BB770Q42658432-3C922EC3-10E1-4754-A6CC-57373CDB82BBQ43641419-037DD985-B561-43A6-8B3F-80633E0801A0Q45875870-03786FA8-86EB-46BE-82F9-7C12C4AA0FF6Q46269755-598C774F-0E4C-40BD-9555-481DE67EA1A8Q47295354-90361A2C-21FF-4279-AA74-05A481F113B7Q47349971-30EEC249-2C98-4870-B73F-F760CC1C8A06Q47880097-CF2F8042-4C2F-4C91-B4D8-C3EA4709E22DQ47929199-7C760811-F560-4BFD-9665-BD1483DC8FA2Q50224199-D0C9FBD4-5788-4FDF-9424-61475D97BEAEQ50263648-ACD8BF00-1EEB-4D4A-A03F-29C2990F742FQ51220913-0E4A8488-AB1C-4820-8734-EE8F2F37CF68Q51363382-FC81CCB6-6A5A-43CC-ABB2-E68651896E19
P2860
Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeted delivery of nanoparti ...... and therapeutic angiogenesis.
@ast
Targeted delivery of nanoparti ...... and therapeutic angiogenesis.
@en
Targeted delivery of nanoparti ...... and therapeutic angiogenesis.
@nl
type
label
Targeted delivery of nanoparti ...... and therapeutic angiogenesis.
@ast
Targeted delivery of nanoparti ...... and therapeutic angiogenesis.
@en
Targeted delivery of nanoparti ...... and therapeutic angiogenesis.
@nl
prefLabel
Targeted delivery of nanoparti ...... and therapeutic angiogenesis.
@ast
Targeted delivery of nanoparti ...... and therapeutic angiogenesis.
@en
Targeted delivery of nanoparti ...... and therapeutic angiogenesis.
@nl
P2860
P50
P356
P1433
P1476
Targeted delivery of nanoparti ...... g and therapeutic angiogenesis
@en
P2093
David J Mooney
P2860
P304
P356
10.1021/NL103812A
P407
P577
2010-12-30T00:00:00Z